MEDIX vs. IMCDX

Last updated Jun 4, 2026

MEDIX (MFS Emerging Markets Debt Fund) and IMCDX (Voya Emerging Markets Corporate Debt Fund) are both Emerging Markets Bonds funds. A 0.71 correlation means they provide meaningful diversification when combined. MEDIX charges 0.81%/yr vs 0.10%/yr for IMCDX.

Performance

MEDIX vs. IMCDX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in MFS Emerging Markets Debt Fund (MEDIX) and Voya Emerging Markets Corporate Debt Fund (IMCDX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

MEDIX

• 1D: 0.16%
• 1M: 1.09%
• YTD: 2.46%
• 6M: 3.09%
• 1Y: 12.40%
• 3Y*: 9.48%
• 5Y*: 2.13%
• 10Y*: 3.73%

IMCDX

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

MEDIX vs. IMCDX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
MEDIX MFS Emerging Markets Debt Fund	2.46%	12.48%	5.92%	9.42%	-15.97%	-2.40%	8.01%	14.12%	-4.99%	9.64%
IMCDX Voya Emerging Markets Corporate Debt Fund	0.00%	0.00%	6.44%	8.51%	-13.79%	0.08%	8.35%	13.65%	-1.77%	9.40%

Correlation

The correlation between MEDIX and IMCDX is 0.71, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (3Y) Calculated over the trailing 3-year period	0.58
Correlation (5Y) Calculated over the trailing 5-year period	0.69
Correlation (10Y) Calculated over the trailing 10-year period	0.72
Correlation (All Time) Calculated using the full available price history since Aug 1, 2012	0.71

The correlation between MEDIX and IMCDX shifts across timeframes, from 0.58 (3 years) to 0.72 (10 years), reflecting how their relationship changes across market environments.

Return for Risk

MEDIX vs. IMCDX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MEDIX

MEDIX Risk / Return Rank: 84
MEDIX Sharpe Ratio Rank: 94
MEDIX Sortino Ratio Rank: 96
MEDIX Omega Ratio Rank: 93
MEDIX Calmar Ratio Rank: 65
MEDIX Martin Ratio Rank: 70

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MEDIX vs. IMCDX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for MFS Emerging Markets Debt Fund (MEDIX) and Voya Emerging Markets Corporate Debt Fund (IMCDX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	MEDIX	IMCDX	Difference
Sharpe ratio Return per unit of total volatility	3.25	—	—
Sortino ratio Return per unit of downside risk	5.40	—	—
Omega ratio Gain probability vs. loss probability	1.70	—	—
Calmar ratio Return relative to maximum drawdown	3.09	—	—
Martin ratio Return relative to average drawdown	13.52	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	MEDIX	IMCDX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	3.25	—	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.36	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.64	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.98	—	—

Drawdowns

Drawdown Indicators

	MEDIX	IMCDX	Difference
Max Drawdown Largest peak-to-trough decline	-35.31%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-4.12%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-7.48%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-27.40%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-27.40%	—	—
Current Drawdown Current decline from peak	0.00%	—	—
Average Drawdown Average peak-to-trough decline	-4.44%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	0.94%	—	—

Volatility

Volatility by Period

	MEDIX	IMCDX	Difference
Volatility (1M) Calculated over the trailing 1-month period	1.39%	—	—
Volatility (6M) Calculated over the trailing 6-month period	3.22%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	3.92%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	5.89%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	5.87%	—	—

MEDIX vs. IMCDX - Expense Ratio Comparison

MEDIX has a 0.81% expense ratio, which is higher than IMCDX's 0.10% expense ratio.

Dividends

MEDIX vs. IMCDX - Dividend Comparison

MEDIX's dividend yield for the trailing twelve months is around 5.04%, while IMCDX has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
IMCDX Voya Emerging Markets Corporate Debt Fund	0.00%	0.00%	4.08%	4.21%	3.80%	6.14%	4.64%	4.99%	5.30%	4.79%	5.22%	5.11%
MEDIX MFS Emerging Markets Debt Fund	5.04%	5.22%	5.68%	4.90%	5.51%	4.33%	4.07%	4.59%	4.87%	4.46%	4.86%	5.25%

Frequently Asked Questions

Can I hold both MEDIX and IMCDX in my portfolio?

MEDIX and IMCDX have a correlation of 0.71, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.